← FDA Drug Approvals (Drugs@FDA)

LENALIDOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2022-09-06

Drug application

FDA Application #

ANDA210435

Application type

Abbreviated New Drug Application (Generic)

Brand name

LENALIDOMIDE

Generic name

LENALIDOMIDE

Active ingredients

LENALIDOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

EXELAN PHARMACEUTICALS INC.

First approval

2022-09-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown